This is a Phase 1 safety/tolerably study to determine if there are clinically significant
interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent
with intravenous (IV) cocaine infusions.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Central Nervous System Stimulants Cocaine gamma-Aminobutyric Acid Vigabatrin